Page last updated: 2024-12-05

phenylhydroquinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Phenylhydroquinone (PHQ) is a synthetic organic compound with the formula C12H10O2. It is a white crystalline solid, that is practically insoluble in water. It is known to be a potent antioxidant and has been studied for its potential therapeutic applications in various diseases. PHQ is synthesized through a multi-step process involving the reduction of p-benzoquinone with phenylmagnesium bromide. Its antioxidant properties are attributed to its ability to donate hydrogen atoms to free radicals, thereby preventing oxidative damage to cells. Research suggests that PHQ has potential anti-inflammatory, anti-cancer, and neuroprotective effects. Its antioxidant and anti-inflammatory activities have been investigated in models of cardiovascular disease, cancer, and neurodegenerative disorders. PHQ is also being explored as a potential therapeutic agent for treating inflammatory bowel disease and other inflammatory conditions. The compound is studied because of its potential to be a safe and effective treatment for various diseases. Its antioxidant properties and potential therapeutic applications make it an active area of research.'

phenylhydroquinone: major metabolite of o-phenylphenol; cleaves DNA; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14116
CHEMBL ID510600
SCHEMBL ID68984
MeSH IDM0182060

Synonyms (56)

Synonym
ai3-19362
einecs 214-091-1
ccris 4279
(1,1'-biphenyl)-2,5-diol
nsc 407988
biphenyl-2,5-diol
brn 1949429
o-phenylhydroquinone
1,4-benzenediol, phenyl-
[1,1'-biphenyl]-2,5-diol
phenylhydroquinone
1079-21-6
2-phenylbenzene-1,4-diol
nsc407988
2-phenylhydroquinone
hydroquinone, phenyl-
1, phenyl-
[1,5-diol
2,5-dihydroxybiphenyl
2,5-biphenyldiol
wln: qr dq br
nsc-407988
2-phenylhydroquinone, 97%
D0584
CHEMBL510600
hydroquinone derivative, 1c
bdbm34125
2-phenylhydroquinone, 7
unii-gpt41t80fj
gpt41t80fj ,
3-06-00-05371 (beilstein handbook reference)
1,1'-biphenyl-2,5-diol
FT-0613336
AKOS015915336
2-phenyl-1,4-dihydroxybenzene
2-phenyl-1,4-hydroquinone
dihydroxybiphenyl, 2,5-
phenyl-p-hydroquinone
1,4-dihydroxy-2-phenylbenzene
2-phenyl-1,4-benzenediol
SCHEMBL68984
DTXSID7051553
AC-26579
phenyl hydroquinone
J-002035
mfcd00002342
AS-58186
3,5-diamino-2,4,6-triiodobenzoicacid
140627-35-6
2,5-biphenyldiol; [1,1'-biphenyl]-2,5-diol
tfiih modulator-12
tfiih modulator12
Q27279224
D89683
2,5-dihydroxybiphenyl, 2,5-biphenyldiol
k3c ,

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" OPP-epoxide and BP were less toxic than the OPP isomers."( Cytotoxic effects of biphenyl and hydroxybiphenyls on isolated rat hepatocytes.
Moldéus, P; Moore, G; Nakagawa, Y; Tayama, S, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1Oryctolagus cuniculus (rabbit)IC50 (µMol)2.29000.00022.81679.0000AID1799278
Testosterone 17-beta-dehydrogenase 3Homo sapiens (human)IC50 (µMol)14.80000.00261.76469.3000AID1799665
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (4)

Processvia Protein(s)Taxonomy
androgen biosynthetic processTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
male genitalia developmentTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
testosterone biosynthetic processTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
steroid biosynthetic processTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
estradiol 17-beta-dehydrogenase [NAD(P)] activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
testosterone dehydrogenase [NAD(P)] activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
testosterone 17-beta-dehydrogenase (NADP+) activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
17-beta-hydroxysteroid dehydrogenase (NADP+) activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
endoplasmic reticulumTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
endoplasmic reticulum membraneTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
intracellular membrane-bounded organelleTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
endoplasmic reticulumTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1799278Determination of Inhibitory Potencies by Coupled ATPase Activity Assay from Article 10.1016/j.bmc.2008.12.010: \\Structure-based virtual screening for novel inhibitors of the sarco/endoplasmic reticulum calcium ATPase and their experimental evaluation.\\2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Structure-based virtual screening for novel inhibitors of the sarco/endoplasmic reticulum calcium ATPase and their experimental evaluation.
AID1799665Inhibition Assay from Article 10.1080/14756360109162353: \\Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.\\2001Journal of enzyme inhibition, Jan, Volume: 16, Issue:1
Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.
AID602814Inhibition of Sarcoplasmic/endoplasmic reticulum calcium ATPase in rabbit hind leg tissue microsomes assessed as inorganic phosphate release by malachite green dye based chromogenic assay2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Discovery of novel SERCA inhibitors by virtual screening of a large compound library.
AID1059430Inhibition of recombinant human IDO1 expressed in Escherichia coli EC538 using L-tryptophan as substrate at 1 mM after 1 hr relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
AID602812Inhibition of Sarcoplasmic/endoplasmic reticulum calcium ATPase in rabbit hind leg tissue microsomes assessed as rate of NADH oxidation coupled to SERCA-catalyzed ATP hydrolysis by spectroscopic assay2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Discovery of novel SERCA inhibitors by virtual screening of a large compound library.
AID367475Inhibition of rabbit hind leg tissue microsomes ATPase activity of SERCA assessed as ATP hydrolysis2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Structure-based virtual screening for novel inhibitors of the sarco/endoplasmic reticulum calcium ATPase and their experimental evaluation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.86)18.7374
1990's19 (54.29)18.2507
2000's11 (31.43)29.6817
2010's4 (11.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.01 (24.57)
Research Supply Index3.58 (2.92)
Research Growth Index5.97 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.86%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (97.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]